ATS 2019 Virtual Final Program

P4 Epithelial Cell-Derived Protein Levels in Bronchoalveolar Lavage Fluid as the Biomarker for Hypoxia from Patients with Acute Eosinophilic Pneumonia/ S.-I. Nureki, M. Yamasue, Y. Usagawa, H. Yoshikawa, K. Hashinaga, R. Takenaka, K. Komiya, K. Umeki, M. Ando, K. Hiramatsu, E. Miyazaki, J.-I. Kadota, Yufu, Japan, p.A2965 P5 Evaluation of Extraction Buffers for Quantifying Peanut Allergens in Settled Dust/ N. Metwali, P.S. Thorne, Iowa City, IA, p.A2966 P6 Real World Practice for Allergic Bronchopulmonary Mycosis (ABPM)/ K. Hanaoka, Y. Onishi, R. Kagami, R. Katsuda, K. Miyake, Y. Mizumori, H. Tsukamoto, S. Sasaki, T. Kawamura, Y. Nakahara, Himeji, Japan, p.A2967 P7 Specific IgE Levels as an Important Diagnostic Marker for the Diagnosis of Children with Allergic Bronchopulmonary Aspergillosis/ M. Singh, A. Chauhan, M. Singh, Chandigarh, India, p.A2968 Facilitator : C. Dinakar, MD, Stanford, CA P8 Allergic Bronchopulmonary Aspergillosis in Acute Severe Asthma- a Cross-Sectional Study/ A.S. Hameed, S.V. Kumar, G. Vishnukanth, A.S. Chauhan, R. Manju, V.S. Negi, V.R. Pandit, Puducherry, India, p.A2969 P9 Allergic Bronchopulmonary Aspergillosis (ABPA) Related Admissions in the United States and It’s Outcomes in Asthmatics/ S. Singh, A. Naaraayan, P. Acharya, M. Durdevic, A.C. Stan, A. Yu, S.H. Jesmajian, M. Mandel, New Rochelle, NY, p.A2970 P10 Efficacy and Safety of Unique Natural Combination Spray for Symptoms Relief in Children with Persistent Allergic Rhinitis/ D. Zujovic, L. Sagic, K. Milosevic, O. Ostojic, Belgrade, Serbia, p.A2971 P11 Trends in Mortality from Eosinophilic Disorders/ A. Asghar, J.D. Salciccioli, D.C. Marshall, P. Akuthota, San Diego, CA, p.A2972 P12 Prevalence of Peripheral Hypereosinophilia in Respiratory Disease/ N. Leverone, S. Tran, P. Akuthota, San Diego, CA, p.A2973 P13 Effects of Cigarette Smoke on Immunological Mechanisms for the Development of Pulmonary Pollen Allergy/ M. Takeuchi, C. Kanamori, Y. Hirano, S. Hamada, M. Uno, H. Nakata, K.E. Pinkerton, Kyoto, Japan, p.A2974 P14 Comparing the Ability of Unfractionated Heparin, Enoxaparin, and Nadroparin to Augment C1 Esterase Inhibitor Activity in Sera of Patients with Hereditary Angioedema/ E.D. Chan, J. Dennis, E. Woroch, B. Hellbusch, B. Shaun, E.P. Schmidt, S. Aerts, M. Bates, R. Fugit, S. Nieto-Martinez, A. Majluf-Cruz, P. Giclas, A. Frazer-Abel, Y. Zhou, Denver, CO, p.A2975 BEHAVIORAL THEMATIC POSTER SESSION B35 EPIDEMIOLOGICAL STUDIES AND MANAGEMENT OF COPD 9:15 a.m. - 4:15 p.m. KBHCCD Area D (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. P429 Difference in Clinical Characteristics of Patients with COPD Exacerbation That Require a Pulmonary Consultation Versus Those Managed by Academic Hospitalist Only/ A. Ghimire, S. Nandavaram, S. Goyal, D. Wang, Syracuse, NY, p.A2976 P430 Pilot Study Evaluating Phenotypic Measurements and Their Relation to Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients/ O. Dyrmishi, C. Devoe, R. Palacholla, S.N. Derakhshani, S. Agboola, K. Jethwani, J.C. Kvedar, Boston, MA, p.A2977 P431 Two-Thirds of Long-Term Acute Care Hospital Transfers Are Inappropriate: Findings from a Multicenter Study of Medicare ACO Beneficiaries/ R.C. Schumacher, K. Krause, M. Chiu, A. Makam, Dallas, TX, p.A2978 P432 Discharge Plan of Care for COPD (DIPLAC): A Personalized, Telehealth-Based Program to Reduce Frequent Emergency Department Visits of Veterans with Acute Exacerbations of COPD in Inner-City Chicago/ Z. Elfessi, M. Tole, H. Pitzele, M. Baumann, J. Hubacek, K. Kolman, A. DePadua, I. Rubinstein, S. Unterman, Chicago, IL, p.A2979 P433 The Multidisciplinary Team (MDT) Management of Chronic Obstructive Pulmonary Disease in the Community/ A. Ali, J. Ibrahim, T. Khan, J. Ahmed, A. Sesan, K.S. Srinivasan, H. Moudgil, E. Crawford, A. Makan, A. Nawaid, Telford, United Kingdom, p.A2980 P434 Multidisciplinary Team Approach to Tackling 30 Day COPD Readmissions and the Challenges Faced at Harlem Hospital Center/ G.L. Rajbhandari, M. Pradhan, L.E. Carrasco Abinader, R. Ayinla, M. Olibrice Saint-Fleur, New York, NY, p.A2981 P435 Directing Future Focus for Telehealth Approaches in COPD Management: Trends that Suggest Positive Outcomes/ D. Tellez, M. Crocker, San Diego, CA, p.A2982 P436 Do Staffing Levels Influence Provision of Best-Practice Care for Chronic Obstructive Pulmonary Disease?/ P. Stone, V. McMillan, K. Mortier, J.K. Quint, C.M. Roberts, London, United Kingdom, p.A2983 Facilitator : K. Hoth, PhD, Iowa City, IA P437 Daily Physical Activity in Patients with COPD After Hospital Discharge in an Underserved Population/ V. Prieto-Centurion, R. Casaburi, D.B. Coultas, M.M. Kansal, S. Kitsiou, J.J. Luo, J. Ma, C.S. Rand, A.-Y.M. Tan, J.A. Krishnan, Chicago, IL, p.A2984 ATS 2019 • Dallas, TX 148 MONDAY • MAY 20